Metraipolis › archive › dc_c4faf8a15ff2

Esketamine use in real-world clinical practice in patients with treatment-resistant depression — Europe PMC PMID:40856202

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40856202
DOI
10.1192/j.eurpsy.2025.10096
License (as archived)
solo-consultazione
Archived
2026-11-10T08:22:56.383Z
SHA-256 of the archived text
d3dc8b51ab44d0757c1fac0e2369194bfceb43d96ba1261baec647bfd4c178d5
Stable URL of this page
https://metraipolis.com/documento/dc_c4faf8a15ff2

How to cite

Esketamine use in real-world clinical practice in patients with treatment-resistant depression — Europe PMC PMID:40856202 — Europe PMC (en), https://europepmc.org/article/MED/40856202 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c4faf8a15ff2 (Metraipolis archive dc_c4faf8a15ff2, sha256 d3dc8b51ab44d0757c1fac0e2369194bfceb43d96ba1261baec647bfd4c178d5)
BibTeX
@misc{dcc4faf8a15ff2,
  title = {Esketamine use in real-world clinical practice in patients with treatment-resistant depression — Europe PMC PMID:40856202},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40856202},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c4faf8a15ff2; sha256 d3dc8b51ab44d0757c1fac0e2369194bfceb43d96ba1261baec647bfd4c178d5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40856202. Agents can read the archived copy with the MCP tool read_document.